| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 18 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: Q4Q9N0
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 139 | 143 | PF00656 | 0.420 |
| CLV_C14_Caspase3-7 | 26 | 30 | PF00656 | 0.716 |
| CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.338 |
| CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.421 |
| CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.421 |
| CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.423 |
| CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.422 |
| DOC_PP4_FxxP_1 | 127 | 130 | PF00568 | 0.434 |
| DOC_PP4_FxxP_1 | 53 | 56 | PF00568 | 0.596 |
| DOC_WW_Pin1_4 | 48 | 53 | PF00397 | 0.599 |
| LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.648 |
| LIG_14-3-3_CanoR_1 | 45 | 54 | PF00244 | 0.595 |
| LIG_BRCT_BRCA1_1 | 140 | 144 | PF00533 | 0.462 |
| LIG_BRCT_BRCA1_1 | 49 | 53 | PF00533 | 0.589 |
| LIG_FHA_1 | 98 | 104 | PF00498 | 0.582 |
| LIG_FHA_2 | 137 | 143 | PF00498 | 0.456 |
| LIG_FHA_2 | 24 | 30 | PF00498 | 0.655 |
| LIG_LIR_Apic_2 | 50 | 56 | PF02991 | 0.594 |
| LIG_LIR_Apic_2 | 68 | 72 | PF02991 | 0.594 |
| LIG_LIR_Gen_1 | 142 | 153 | PF02991 | 0.361 |
| LIG_LIR_Nem_3 | 142 | 148 | PF02991 | 0.394 |
| LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.601 |
| LIG_LIR_Nem_3 | 68 | 73 | PF02991 | 0.595 |
| LIG_PDZ_Class_3 | 151 | 156 | PF00595 | 0.368 |
| LIG_SH2_SRC | 88 | 91 | PF00017 | 0.678 |
| LIG_SH2_STAP1 | 61 | 65 | PF00017 | 0.636 |
| LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.307 |
| LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.289 |
| LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.254 |
| LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.634 |
| LIG_SH3_3 | 143 | 149 | PF00018 | 0.416 |
| LIG_SUMO_SIM_par_1 | 99 | 108 | PF11976 | 0.589 |
| LIG_TRFH_1 | 126 | 130 | PF08558 | 0.289 |
| LIG_UBA3_1 | 103 | 111 | PF00899 | 0.577 |
| MOD_CK1_1 | 136 | 142 | PF00069 | 0.416 |
| MOD_DYRK1A_RPxSP_1 | 48 | 52 | PF00069 | 0.587 |
| MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.556 |
| MOD_N-GLC_1 | 31 | 36 | PF02516 | 0.441 |
| MOD_NEK2_1 | 2 | 7 | PF00069 | 0.614 |
| MOD_PK_1 | 3 | 9 | PF00069 | 0.581 |
| MOD_PKA_1 | 3 | 9 | PF00069 | 0.686 |
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.651 |
| MOD_PKA_2 | 47 | 53 | PF00069 | 0.591 |
| MOD_Plk_1 | 131 | 137 | PF00069 | 0.358 |
| MOD_Plk_4 | 60 | 66 | PF00069 | 0.630 |
| MOD_ProDKin_1 | 48 | 54 | PF00069 | 0.601 |
| TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.284 |
| TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.282 |
| TRG_NLS_Bipartite_1 | 93 | 113 | PF00514 | 0.557 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P8V9 | Leptomonas seymouri | 87% | 100% |
| A0A0S4JP84 | Bodo saltans | 62% | 100% |
| A0A1X0NYC2 | Trypanosomatidae | 76% | 100% |
| A0A3R7P4M5 | Trypanosoma rangeli | 75% | 100% |
| A0A3S7WZB6 | Leishmania donovani | 99% | 100% |
| A4HEB1 | Leishmania braziliensis | 91% | 73% |
| A4I1Q7 | Leishmania infantum | 99% | 100% |
| C9ZKB2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
| E9AXU1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |